GRAYBUG VISION INC (GRAY) Stock News
NASDAQ:GRAY - Nasdaq - US38942Q1031 - Common Stock - Currency: USD
GRAY Latest News, Press Relases and Analysis
Graybug Announces Name and Trading Symbol Change
REDWOOD CITY, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY) (Graybug) today announced that it has changed its name to...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, FMIA, GRAY
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Mentions: BLI
Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News
Today, investors in Graybug Vision and GRAY stock are cheering an announced strategic review, which could see a sale of the company.
Shareholder Alert: Ademi LLP investigates whether Graybug Vision, Inc. has entered into a Fair Transaction with CalciMedica
/PRNewswire/ -- Ademi LLP is investigating Graybug (Nasdaq: GRAY) for possible breaches of fiduciary duty and other violations of law in its transaction with...
GRAY STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Graybug Vision, Inc. Is Fair to Shareholders
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday morning!
Graybug Vision, CalciMedica to merge in all-stock transaction (NASDAQ:GRAY)
Graybug Vision (GRAY) and CalciMedica have entered into a definitive merger pact to combine the companies in an all-stock transaction
Graybug and CalciMedica Enter into Definitive Merger Agreement
– Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica’s pipeline of first-in-class product candidates...
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
REDWOOD CITY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY) (“Graybug” or the “Company”), a clinical-stage...
Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments
BALTIMORE, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing...
Graybug to Present at the 2022 OIS Retina Innovation Summit
BALTIMORE, July 06, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing...
Graybug Announces Review of Strategic Alternatives
BALTIMORE, June 28, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing...
Graybug to Present Clinical Development Plan Update for GB-102 at the 2022 Clinical Trials at the Summit Meeting
BALTIMORE, May 19, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing...